| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.9 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |